Airsculpt Technologies Inc
NASDAQ:AIRS
Airsculpt Technologies Inc
Accrued Liabilities
Airsculpt Technologies Inc
Accrued Liabilities Peer Comparison
Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Accrued Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Airsculpt Technologies Inc
NASDAQ:AIRS
|
Accrued Liabilities
$12.8m
|
CAGR 3-Years
40%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
DaVita Inc
NYSE:DVA
|
Accrued Liabilities
$1B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
5%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Accrued Liabilities
$153m
|
CAGR 3-Years
2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
CVS Health Corp
NYSE:CVS
|
Accrued Liabilities
$24.1B
|
CAGR 3-Years
15%
|
CAGR 5-Years
15%
|
CAGR 10-Years
17%
|
|
Cigna Corp
NYSE:CI
|
Accrued Liabilities
$8.9B
|
CAGR 3-Years
2%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Accrued Liabilities
$820.6m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
9%
|
See Also
What is Airsculpt Technologies Inc's Accrued Liabilities?
Accrued Liabilities
12.8m
USD
Based on the financial report for Dec 31, 2023, Airsculpt Technologies Inc's Accrued Liabilities amounts to 12.8m USD.
What is Airsculpt Technologies Inc's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 3Y
40%
Over the last year, the Accrued Liabilities growth was -9%. The average annual Accrued Liabilities growth rates for Airsculpt Technologies Inc have been 40% over the past three years .